BioSpace News Archive

Pharm Country

NYU Langone Health Study Shows Lithium Chloride Blunts Brain Damage Linked to Fetal Alcohol Syndrome

A single dose of lithium chloride, a drug used to treat bipolar disease and aggression, blocks the sleep disturbances, memory loss, and learning problems tied to fetal alcohol syndrome, new experiments in mice show.

December 5, 2017

·

3 min read

Biotech Beach

Ambry Presents Research Expanding Our Understanding of Gene Disease Relationships at the San Antonio Breast Cancer Symposium

Ambry Genetics (Ambry), a leading clinical genetics-testing lab, is presenting data this week at San Antonio Breast Cancer Symposium (SABCS) to help the medical community further understand the genetic mutations behind hereditary breast cancer, which accounts for up to 10% of all breast cancer diagnoses.

December 5, 2017

·

3 min read

Drug Development

Zymeworks Presents Results of the Completed Dose Escalation Portion of the Ongoing Phase 1 Study of ZW25 at the San Antonio Breast Cancer Symposium

Zymeworks presented the completed dose escalation portion of its Phase 1 study of ZW25, a novel Azymetric bispecific antibody targeting two distinct domains of the HER2 receptor.

December 5, 2017

·

9 min read

GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation

GB Sciences explains that 100% of the mother plants in their Las Vegas cultivation facility are now products of the GB Sciences tissue propagation initiative.

December 5, 2017

·

4 min read

BioForest

Lumen Raises $13M for New Biotech Production Platform

Lumen Bioscience announced today it has raised $13 million of new capital, including a Series A investment round totaling $11.2M and a $1.8M grant from the US Department of Energy.

December 5, 2017

·

4 min read

Drug Development

Realm Therapeutics Announces First Patient Dosed in Phase II Study of PR022 for the Treatment of Atopic Dermatitis

The Phase 2 study is a randomized, double-blind, vehicle-controlled, multicenter, parallel-group study assessing the safety and efficacy of multiple doses of PR022 in approximately 120 adult patients with mild-to-moderate atopic dermatitis.

December 5, 2017

·

4 min read

Policy

Oncolytics Biotech Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN in Metastatic Breast Cancer

The Letter refers to the proposed use of pelareorep in combination with paclitaxel, for the treatment of hormone receptor positive, HER2 receptor negative metastatic breast cancer patients in a pivotal phase 3 registration study.

December 5, 2017

·

5 min read

Genetown

Verastem to Present Results From Pivotal Phase 3 DUO Study in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at a Research and Development Event at ASH 2017

The event will take place on Sunday, December 10, 2017 in Atlanta.

December 5, 2017

·

4 min read

Stryker Nabs FDA OK for Cementless Mako Total Knee

FDA

In2Bones Announces FDA Clearance of the CoLink View “See-Through” Plating System

The CoLink View is the sixth In2Bones PEEK-related implant system that has received FDA clearance; others are expected to be cleared in 2018.

December 5, 2017

·

3 min read

Genetown

Acceleron to Host Conference Call and Webcast to Review Data Presented at the 59th American Society of Hematology Annual Meeting and Exposition

Acceleron Pharma will host a conference call and live audio webcast on Monday, December 11, 2017 at 7:00 a.m. EST to review highlights from its Phase 2 clinical presentations at the 59th ASH Annual Meeting and Exposition taking place December 9-12, 2017 in Atlanta, Georgia.

December 5, 2017

·

1 min read